“Evonik is active in more than 100 countries around the world and goes far beyond chemistry to create innovative, profitable, and sustainable solutions for our customers. Evonik’s Health Care business line is a global innovation hub for the world’s leading life science companies from the pharmaceutical, nutraceutical and medical device industries. We support customers along the entire product cycle from early development to commercial manufacturing. Our system solutions are backed by the scientific excellence of our interdisciplinary and diverse teams.” | Evonik Health Care offers a broad portfolio of cell culture ingredients and related services as a technology platform which contributes to highly effective drug development. Our cell culture solutions can be used in the manufacturing of therapeutic proteins like monoclonal antibodies, as well as in the production of viral vectors for gene therapy and specific cells for cell therapy. Our portfolio helps you to ensure optimal growth and viability of cells, enabling the efficient production of biopharmaceutical drugs. The Evonik production network relies on decades-long manufacturing experience and an excellent degree of backward integration to ensure the highest level of quality control and the reliable supply of critical cell culture ingredients. Are you faced with upstream challenges in cell culture? Our Global Competence Network for Cell Culture Solutions is your primary resource when you are looking for system solutions to enhance your media and processes. Whether you would like to intensify a process or scale it up, our multidisciplinary team is ready to help. Our network includes experts in business, application technology, and research and development covering chemistry, cell biology, bioprocessing and media optimization. Our commitment to innovation extends beyond our products. As a solutions provider, we are dedicated to helping biopharma companies and media manufacturers navigate the complex regulatory environment and market access challenges. Building up on our strong expertise in biotechnology and biosolutions, we provide application support and media formulation guidance to help you boost the cell culture performance while reducing complexity and cost of biopharma production. | The Health Care business at Evonik is a global innovation hub for the world’s leading life science companies. We support customers across the entire product lifecycle – from early development to commercial manufacturing – with a broad portfolio of advanced drug delivery technologies, CDMO services for APIs and HPAPIs, and high-performance biopharma solutions. Backed by scientific excellence, sustainability, and a trusted network of western-based facilities, we help the world’s leading life science companies accelerate innovation and improve patient outcomes – today and tomorrow. Evonik is a leading global specialty chemicals company headquartered in Essen, Germany, operating in over 100 countries. Focused on high-growth megatrends like health, nutrition, and sustainability, Evonik develops innovative, tailor-made products for industries ranging from pharmaceuticals and automotive to agriculture. | Evonik is a leading specialty chemical manufacturer of additives, bismaleimide resins, thermoplastic resins and semi-finished products used in composite products and markets worldwide. | Discover Smart Effects, where innovation meets sustainability. Our advanced solutions, leveraging the synergy of silica and silanes, cater to diverse industries including green mobility, agriculture, and food. By utilizing cutting-edge technologies and efficient processes, Smart Effects delivers exceptional value and performance. We are committed to driving positive change with eco-friendly products that benefit both our customers and the planet. Join us in shaping a smarter, greener future with Smart Effects. | For more than 50 years Evonik has served customers worldwide with innovative products and services for medical devices. With our global team of experts we support you at every stage of your product development. We offer a comprehensive portfolio of customized biomaterials and services that open up new possibilities for patient-specific treatment, empowering our customers to bring their ideas to life. | Evonik’s performance additives and dispersing agents for the plastics industry improve the production process and final quality of products. With ongoing challenges around upcoming regulations, the cost and availability of raw materials, and reducing energy use, the plastics industry continues to come under increasing pressure to improve sustainability through better recycling, waste reduction and resource efficiency. The only way to achieve all of this is through continuous innovation. | Evonik Care Solutions is a leading sustainable specialties partner for companies in the beauty and personal care industries. Evonik offers a broad portfolio of innovative ingredients, technologies, and services that enable customers to achieve superior sustainability and functionality in their formulations. Recognized as a powerhouse and global leader, Evonik operates across a diverse range of markets and applications, including active ingredients, active delivery systems, skin care, sun care, color cosmetics, hair care, skin cleansing, alternative preservation, and product stability. | Evonik provides market-relevant and technologically differentiated products for the personal care and oral care industries. Evonik’s Care Solutions portfolio includes solutions for formulation design, innovative emulsifiers, emollients, product protection, natural alternative preservatives, and active ingredients, including clinically-tested ceramide, peptide, delivery system, and botanicals. Evonik Silica’s broad and diverse portfolio is designed to fit consumer’s needs in silica shape, size, distribution, flexibility, compatibility, and application skin-feel and appearance, providing personal care solutions for skincare, decorative cosmetics, rinse-off formulations, and oral care solutions for whitening and sensitive toothpastes. | Evonik Industries, a global chemical company, develops and manufactures specialty chemicals for various products and markets worldwide.Providing solutions to the packaging industry, Evonik’s Coating & Adhesive Resins Business Line offers DEGACRYL® HS, a range of methacrylic polymers for applications like dairy or pharmaceutical packaging.DEGACRYL® HS binders are THE major ingredient for high-quality coatings and are known for their secure seal and smooth peel capabilities. DEGACRYL® HS not only offers direct adhesion to aluminum, PET and paper, but also seals to all common substrates, like polystyrene, polypropylene, polyethylene and many more – all while being free of styrene and PVC.In order to reduce plastic waste, Evonik offers sustainable DEGACRYL® HS grades that enable NIR sorting of plastics and improve recycling efficiency by enabling mono material packaging. Furthermore, recyclability of paper packaging coated with DEGACRYL® HS is possible without having to compromise seal strength or barrier properties. | Evonik is a world leader in the manufacture of high performance products supporting lightweight design, 3D printing and efficient production of fiber-reinforced composites. It supplies foam core materials for sandwich construction, plus thermoplastic & thermosetting resin matrices and their components, including crosslinkers, catalysts, methacrylates, impact strength modifiers and process additives. | Evonik’s High Performance Polymers takes you on the move with its solutions for electric and hybrid vehicles. When developing today’s high-voltage automotive electrical systems, manufacturers rely on VESTAMID® polyamide 12 for the most crucial electric vehicle battery components including busbars and cooling lines for battery packs, and VESTAKEEP® for wire windings in electric motors. | Evonik Protectosil(R) portfolio of water repellents, corrosion inhibitors, ANTIGRAFFITI(R) and easy to clean products are designed to protect and preserve precast and masonry.
Eurogentec
Eurogentec is an international company founded in 1985 and part of Kaneka Corp. since 2010. Headquartered in Liege (Belgium) it provides products and services to scientists involved in the life science research, molecular diagnostics and therapeutic developments. Eurogentec has production sites in Europe and United States of America. The company is recognized as one of the major suppliers in the field of genomics and proteomics as well as a trusted US FDA inspected Contract Development and Manufacturing Organization (CDMO) for the bio-production of pharmaceuticals (vaccines and medicines). | Founded in 1985 and part of Kaneka Corporation since 2010, Eurogentec is a leading biotechnology and CDMO company specializing in GMP-certified manufacturing of starting materials and APIs. With facilities in Europe and the USA, we support plasmid DNA, mRNA, recombinant proteins, peptides, antibody fragments, and therapeutic oligonucleotides from early research to clinical and commercial production. Our expertise in process development and scale-up ensures high-quality solutions at every stage. Detailed Description of Products (Event Specific) max 500 characters in English – Plasmid DNA : Starting material & APIs including Nano-plasmids & Minicircle DNA. FastTrack: 4-month production. – mRNA : IVT mRNA (0.1g–50g), saRNA, gRNA with co-/post-transcriptional modifications. – Proteins : GMP production in E. coli & P. pastoris for biotech & pharma. – Conjugates : Chemically modified recombinant proteins for clinical use. – Therapeutic Oligos : ASOs, siRNA, aptamers, CpG oligos. – Peptides : Linear, cyclic & complex-modified. – Antibody Fragments : scFv, Fab, VHH, bispecifics. | Eurogentec—part of Kaneka Corp. since 2010—is a leading international company founded in 1985 and headquartered in Belgium. Accredited by the Belgian AFMPS, US FDA, and Japanese MHLW, we deliver trusted solutions to the life sciences, molecular diagnostics, and therapeutic development sectors. As a major supplier in genomics (oligonucleotides, qPCR kits, reagents) and proteomics (custom and catalog antibodies, peptides), we also act as a reliable CDMO for process development and GMP manufacturing of vaccines and medicines—including therapeutic oligonucleotides, peptides, plasmids, recombinant proteins, mRNA and VHH antibodies. Our comprehensive services cover process transfer, development and optimization, scale-up, tox and clinical batches, GMP and GMP-like manufacturing, Quality Control, QA release, and ICH stability studies. From early-phase development to commercialization, Eurogentec is your single partner for every step of the journey.
Enzene
Enzene is an end-to-end CDMO with services spanning discovery, development, and commercial supply, operating integrated sites in Pune (India) and New Jersey (USA). As a pioneer in next-generation biologics technologies, Enzene is disrupting the existing biologics manufacturing paradigm with its patented EnzeneX™ technology, which was the first fully-connected continuous manufacturing™ (FCCM™) platform validated for commercial biologics supply. We partner with innovators and biosimilar developers to deliver accelerated time-to-market, increased production yields, and cost reductions across a broad range of biologic modalities. Committed to pushing the boundaries of biologics manufacturing innovation, Enzene is striving to reduce monoclonal antibody production costs to below $40 per gram by 2025. Our microbial and mammalian drug substance plants, as well as our sterile fill & finish plant in India are EU-GMP certified. | Enzene is a leading global continuously innovative development and manufacturing organization (CIDMO). The company was founded on a belief that we have a responsibility to positively impact healthcare around the world by providing the technological expertise, passion for innovation, and dedication to helping clients bring accessible and affordable products to market. Built on a proven history of successful commercial launches and a strong early-stage product pipeline, Enzene continues to disrupt the CDMO industry with novel processes that improve quality and productivity while reducing costs and carbon footprint. Our comprehensive capabilities encompass R&D, analytics, and GMP manufacturing, empowering us to offer innovative, high-quality solutions that meet diverse client needs. By providing end-to-end CDMO services for biologics, from cell line development to fill & finish for complex molecules, we are a versatile CDMO partner for our clients across a wide array of modalities. And with multiple manufacturing lines at our Pune, India and New Jersey, USA facilities, Enzene is strategically positioned to meet the escalating demand for biologics and biosimilars across both hemispheres. Additionally, our proprietary continuous manufacturing technology, EnzeneX™, sets us apart as visionaries in the industry, driving healthcare advancement and setting new standards for biologics development and manufacturing. The EnzeneX™ platform optimizes quality, efficiency, and flexibility while supporting cost-effective, sustainable production of top-tier biologics, thereby improving global patient access. At Enzene, we are leaders who seek to solve today’s biotech challenges as well as tomorrow’s by upholding our core values of innovation, integrity, excellence, entrepreneurship, candor, and respect.
EMD Serono
EMD Serono, the healthcare business sector of Merck KGaA, Darmstadt, Germany, in the US and Canada, is a science-led organization dedicated to making a meaningful difference in the lives of people affected by cancer. Our oncology research aims to leverage our synergistic portfolio to tackle challenging tumor types, as we work to illuminate a path to scientific breakthroughs to transform patient outcomes. Learn more at www.emdseronooncology.com | We are the healthcare business in the U.S.A. & Canada for Merck KGaA, Darmstadt, Germany, a vibrant science and technology company. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. The passion of our curious minds makes a positive difference to millions of people’s lives every day. In Healthcare, we discover unique ways to treat the most challenging diseases, such as multiple sclerosis and cancer. Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information. Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live. We are curious minds dedicated to human progress. | In Healthcare, we are at the forefront of developing pioneering therapies – boldly aiming to meaningfully change the lives of patients, their families, and their caregivers. We are unlocking leaps in highly specialized fields with significant unmet medical needs. We leverage internal discoveries and external partnerships to serve patients who need it most across all continents. As one company, science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. The passion of our curious minds makes a positive difference to millions of people’s lives every day. Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information. Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live. We are sparking discovery, elevating humanity. | We are the healthcare business in the U.S.A. & Canada for Merck KGaA, Darmstadt, Germany, a vibrant science and technology company. EMD Serono Aspires to create, improve and prolong lives — As One for Patients. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. The passion of our curious minds makes a positive difference to millions of people’s lives every day. In Healthcare, we discover unique ways to treat the most challenging diseases, such as multiple sclerosis and cancer. Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information. Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live. We are curious minds dedicated to human progress.
EirGenix, Inc.
EirGenix is the leading company in biologics development and GMP manufacturing and has solid experience in various biologics (mAb, bi-specific mAbs, r-proteins, COVID-19 Spike protein, fusion proteins, RNA, ADC, Viral Vector, etc.). As of now, we have successfully completed more than 70 biologics projects for clients all over the world. Moreover, we have signed global licensing collaborations with Sandoz for our Trastuzumab biosimilar (EG12014), which BLA has been submitted to the US FDA in December 2021. Among others, our services include: – Up to 12×2,000L SUB mammalian cGMP production capacity – Dual cell Line development & banking for mammalian and microbial systems – Upstream/Downstream process development – Analytical and QC – One-stop full service from DS to DP – US FDA inspected and the EIR report received – Japan PMDA and Taiwan FDA certified – Biosimilars pipeline available for licensing and or collaboration | EirGenix is a leading CDMO in biologics development and GMP manufacturing that has solid experience in various biologics (mAb, BsAbs, r-proteins, COVID-19 Spike protein, fusion proteins, ADC, pDNA, Viral Vector, etc.). We have completed > 70 biologics projects for clients all over the world. Moreover, we have signed global licensing collaborations with Sandoz for our Trastuzumab biosimilar (EG12014), which BLA was approved in the EU and waiting for US FDA approval. Among others, our services include: – One-stop full service from DS to DP CGMP Clinical and Commercial manufacturing of Microbial and Mammalian strains – Up to 12 x 2,000L mammalian capacity – Dual Cell Line Development & banking for mammalian and microbial systems – Upstream/Downstream process development – Analytical and QC – US FDA, Japan PMDA, Australia TGA, EU EMA, and Taiwan FDA inspected – Biosimilars pipeline available for licensing and or collaboration | EirGenix is Taiwan’s leading biologics CDMO, providing end-to-end development and manufacturing solutions that meet FDA, PMDA, EMA, and TGA standards. Since 2012, we have successfully delivered 100+ projects across mammalian and microbial platforms, supporting global clients from early-stage development to commercialization. Our comprehensive services include cell line development, process and analytical development, and cGMP manufacturing for both clinical and commercial supply. With a robust 12 × 2,000L single-use bioreactor capacity and expanding microbial fermentation capabilities, we are equipped to handle large-scale production needs. Award-Winning Excellence Since 2017, EirGenix has been consistently recognized for excellence in biologics development and manufacturing, earning multiple prestigious industry awards that demonstrate our commitment to innovation and quality. Recent Awards (2023-2025): – Best ADC CDMO in Taiwan – Asia Pacific Biopharma Excellence Awards 2025 – Most Promising Monoclonal Antibodies Pipeline – Taiwan Biopharma Excellence Awards (TBEA) 2024 – National Science and Technology Drug R&D Award – Gold Medal (2023, Taiwan) (for EirGasun® 150mg) – BioProcessing Excellence Award – Greater China Region (2022) (IMAPAC Asia Biologics – Manufacturing Conference) Accelerate your biologics development with EirGenix. Visit us at BIO 2025 or contact us to explore tailored solutions for your next project.
Ecolab Life Sciences
Ecolab’s Purolite™ Resins receive continued investment from Ecolab to support development, production, and customer support. We have one of the industry’s largest technically trained sales teams in ion exchange and specialty resin technology, backed by five Research and Development centers, nine application labs and five production facilities. With our ability to quickly respond, supply, and develop, we can solve your application challenges and optimize your system. Ecolab’s Life Sciences division is dedicated to developing the best possible products and services to support our customers in the pharmaceutical industry. Our comprehensive solutions and technical expertise are focused on cleaning, sanitization and contamination control, all while ensuring safety, compliance and operational efficiency. Our strategy is to stay focused on two core areas: Global Trends and Regulatory Changes that impact your operations, and develop solutions to keep you on the cutting edge. | Ecolab Life Sciences is a segment of Ecolab and a global leader in technologies and services designed to enhance productivity, reduce costs, and accelerate the development of critical medicines. Leveraging over a century of innovation, Ecolab Life Sciences provides comprehensive solutions and expert guidance across bio-decontamination, drug purification, active pharmaceutical ingredients (APIs) and excipients. With a strong commitment to ensuring safety, compliance, and operational efficiency, Ecolab Life Sciences partners with organizations to support their mission of advancing health and wellbeing worldwide.
Dr. Reddy’s Biologics
Dr. Reddy’s Biologics is a global player in biosimilars, driven by our purpose of accelerating access to innovative medicines. Over the last 25 years, we’ve developed robust capabilities in development, manufacturing, and commercialization, focusing on oncology and immunology. With teams in Hyderabad, Basel, and New Jersey, our cGMP manufacturing facility in Hyderabad is WHO-approved and integrates drug substance and drug product manufacturing. Our R&D team has diverse capabilities, from cell line development to clinical trials, allowing us to develop high-quality biosimilars for global markets. We’ve launched several biosimilar products, with more in the pipeline. Our recent partnerships and successful studies demonstrate our commitment to expanding our portfolio and making a difference in patients’ lives worldwide. | We at Dr. Reddy’s Biologics enable access to high-quality, cost-competitive biosimilars. The future we imagine is one where patients worldwide find ease in illness, every day. Our state-of-the-art manufacturing facilities and end-to-end capabilities bring this future within reach making us a leading biosimilars manufacturer. | We are dedicated to providing access to affordable and innovative medicines, driven by our purpose of ‘Good Health Can’t Wait’. Our products and services span across Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars, and over-the-counter pharmaceutical products globally.
Daicel Life Sciences
Daicel Life Sciences provides products for the increasingly complex needs of the Pharmaceutical and related businesses. Included in these capabilities are the following: Daicel’s world-leading Chiral Chromatography products and services, which are routinely used in the development and manufacture of pharmaceutical ingredients. The innovative Actranza® Jet Injection device, used to deliver biologicals, including Nucleic acids, without the use of needles, LNPs or other carriers. Delivery can be SC, ID, or IM. Pharmaceutical Standards for identification and quantification of drug materials. The most recent entry in our Life Sciences portfolio is an Exosome Isolation System which is designed to process up to 5 liters of feed into 20 ml in less than 2 hours. This proprietary system utilizes both chromatography and tangential flow filtration in a fully automated robust process, allowing for easy and efficient isolation of exosomes, with yield and purity rivalling that of any other method. | Daicel Life Sciences provides products and services to a wide array of the Pharmaceutical market. In the area of drug delivery, our Actranza lab. device is designed to inject biological drugs intra-cellularly without the use of carriers, excipients, or vectors of any kind. In animal studies, this unique needle-free injector has been proven to deliver mRNA and DNA into the cell and achieve production of the desired protein or antibody. | Daicel is a diversified technology company with unique capabilities that are being applied to a wide variety of applications, including Medical-grade plastics, Life-saving air bags, Engineered plastics, and the products of our Life Science SBU. Daicel’s Life Sciences SBU provides products for the increasingly complex needs of the Pharmaceutical and related businesses. Included in these capabilities are the following: Daicel’s world-leading Chiral Chromatography products and services, which are routinely used in the development and manufacture of pharmaceutical ingredients. The innovative Actranza® Jet Injection device, used to deliver RNA and DNA vaccines intracellularly without the use of needles, LNPs or other carriers. Pharmaceutical Standards for identification and quantification of drug materials. The most recent entry in our Life Sciences portfolio is an Exosome Isolation System which is designed to process up to 5 liters of feed into 20 ml in less than 2 hours. This proprietary system utilizes both chromatography and tangential flow filtration in a fully automated robust process, allowing for easy and efficient isolation of exosomes, with yield and purity rivalling that of any other method.
Cytovance Biologics
Cytovance Biologics, Inc. (Cytovance Biologics) is a leading biopharmaceutical contract development and manufacturing organization (CDMO) that excels in the rapid and cost-effective development and manufacture of large molecule active pharmaceutical ingredients (APIs). Cytovance Biologics utilizes both mammalian cell culture and microbial fermentation to express monoclonal antibodies, fragment antibodies, bispecifics, enzymes, fusion proteins, vaccines, and other biological products, including plasmid DNA and cell-based therapeutics. In addition to its clinical and commercial CGMP API manufacturing services, Cytovance Biologics offers well-integrated development services supporting the entire product lifecycle, including cell line development, cell banking, microbial strain development, process and analytical development, and process characterization. Our state-of-the-art facilities in Oklahoma City are designed to meet United States, European Union, and other global regulatory standards. Cytovance Biologics offers deep industry expertise and unique customized services for the scale-up and CGMP manufacture of protein-based therapeutics; from early-stage pre-clinical development to commercial production, for both mammalian and microbial. Further information can be found at www.cytovance.com. | Cytovance® Biologics is a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) offering ingenuity and integrated development services to support large molecule biologics throughout the journey from R&D to regulatory approval. These services include mammalian cell line development, cell banking, microbial strain development, process and analytical development, process characterization, and cGMP manufacturing. The company’s 140,000+ sq. ft. state-of-the-art facilities in America’s Heartland are designed to meet US, EU, and global regulatory requirements. Find out more at https://cytovance.com/ | Streamline your biomanufacturing with a US-based partner that is large enough to support you at every stage but small enough to stay agile and provide your program with the care it deserves. Cytovance® Biologics is a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) offering ingenuity and integrated development services to support large molecule biologics throughout the journey from R&D to regulatory approval and commercial supply. These services include mammalian cell line development, cell banking, microbial strain development, process and analytical development, process characterization, and cGMP manufacturing. The company’s 140,000+ sq. ft. state-of-the-art facilities in America’s Heartland are designed to meet US, EU, and global regulatory requirements.
Cytiva
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery. We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more. | Diagnostic assays like the ones you’re developing are in demand. Set yourself up for success by choosing a supplier that delivers quality products for your entire workflow and offers specialized services and capabilities needed to commercialize your assays. Using a single supplier for multiple components, from membranes to magnetic beads, can streamline your development process and ultimately accelerate the commercialization of diagnostic assays and kits. Cytiva can help you speed up and scale up without staffing up! With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical knowledge and talent, a broad and deep portfolio, and exceptional service to support biotechs at every stage from discovery to delivery. Visit cytiva.com/diagnostics to learn more. | Cytiva and Pall Life Sciences have come together to deliver the breadth, depth, and scale researchers and biopharma need to advance future therapeutics – from discovery to delivery. Together, as Cytiva, we supply the tools and support our customers need to work better, faster and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. | Cytiva is a global life sciences leader that works with academic and translational researchers, developers and manufacturers of biotherapeutics, cell and gene therapies, and new technologies such as mRNA, to enable the delivery of transformative medicines. Cytiva is a trusted expert with nearly 10 000 associates in 43 countries dedicated to customers’ speed, flexibility, capacity and efficiency in drug discovery, research, and manufacturing.